Local

Medtronic, Sanofi Join On Diabetes Drugs, Devices

View Comments
Medtronic, building, generic

(credit: CBS)

CBS Minnesota (con't)

Affordable Care Act Updates: CBSMinnesota.com/ACA

Health News & Information: CBSMinnesota.com/Health

Today's Most Popular Video
  1. Pet Of The Week: Marie, A Chihuahua Mix
  2. More Holiday Photos From 'WCCO This Morning' Viewers
  3. 4 Things To Know For Dec. 19, 2014
  4. Twin Cities Community Gospel Choir Performs Live
  5. WCCO Viewers' Choice For Best Place To See Santa In MN

MINNEAPOLIS (AP) — Medical device manufacturer Medtronic Inc. and French drugmaker Sanofi have joined in a project to develop new combinations of drugs and devices for diabetes care.

The two major companies announced Saturday the “global strategic alliance,” which they said was aimed at improving experience and results for people with diabetes around the world. The companies say the initial priorities will be developing drug-device combinations and providing care-management services to simplify insulin treatment.

Paris-based Sanofi has expertise in developing insulin drugs while Minneapolis-based Medtronic makes insulin pumps and devices for monitoring glucose to control blood sugar.

According to the World Health Organization, an estimated 347 million people worldwide have diabetes. In the U.S., about 30 million people have the disease.

(© Copyright 2014 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed.)

View Comments
blog comments powered by Disqus
Follow

Get every new post delivered to your Inbox.

Join 2,381 other followers